Thus, using the targeted scaffold protein, affibody ZHER2:342, and carbodiimide chemistry, we obtained HER2-specific nanoparticles capable of generating ROS under external irradiation with light and specifically targeting cancer cells. Here, ERBB2 is linked to cancer.